Health Catalyst HCAT Income Statement (2018-2026)

NASDAQ HCAT
$1.69 -0.02 (-1.17%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Health Catalyst Quarterly Income Statement

Periods 33 quarters
Latest Jun 2026

Health Catalyst reported revenue of $70.49M and net income of -$40.54M for the quarter ended Jun 2026, down 12.7% year over year. This income statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
61.74M64.72M68.09M70.63M68.35M69.16M73.87M73.21M73.77M75.08M74.72M75.90M76.35M79.61M79.41M80.72M76.32M74.68M70.76M70.49M
Cost of RevenueCost of Rev
33.09M33.88M34.00M34.61M36.34M38.11M38.30M39.44M41.79M44.58M38.52M40.06M42.31M44.91M43.18M42.48M38.51M35.30M35.29M35.63M
Gross Profit
28.65M30.84M34.09M36.03M32.01M31.06M35.56M33.77M31.99M30.51M36.21M35.84M34.04M34.69M36.23M38.24M37.82M39.38M35.46M34.86M
Operating items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
1.70M2.00M2.30M2.60M3.00M3.20M3.20M3.20M3.10M3.10M3.30M3.10M3.10M3.30M3.60M3.60M3.80M4.00M4.00M3.70M
Research & DevelopmentR&D
20.81M21.86M20.82M20.92M25.40M20.37M18.57M17.59M17.67M20.29M19.06M13.88M14.19M14.80M15.19M13.21M14.36M10.17M10.59M11.03M
Selling, General & AdministrativeSG&A
23.06M25.34M8.82M17.54M19.19M16.15M23.83M23.67M13.62M15.43M14.56M14.36M12.21M15.68M14.16M8.28M16.07M11.04M13.96M11.93M
Other Operating ExpensesOther Opex
25.34M26.40M26.50M28.16M30.14M28.08M24.88M23.93M22.17M24.48M22.10M20.30M18.23M18.41M23.46M50.24M21.09M100.25M113.39M44.69M
Operating ExpensesOpex
70.90M75.60M58.44M69.22M77.73M67.80M70.48M68.39M56.57M63.29M59.02M51.65M47.73M52.19M56.41M75.33M55.33M125.46M141.94M71.34M
Operating IncomeOp. Inc
-42.25M-44.77M-24.35M-33.19M-45.72M-36.74M-34.91M-34.62M-24.58M-32.78M-22.81M-15.81M-13.69M-17.50M-20.17M-37.09M-17.51M-86.08M-106.48M-36.48M
EBIT
-42.25M-44.77M-24.35M-33.19M-45.72M-36.74M-34.91M-34.62M-24.58M-32.78M-22.81M-15.81M-13.69M-17.50M-20.17M-37.09M-17.51M-86.08M-106.48M-36.48M
Non-operating items
Non Operating Interest Expenses
4.42M4.38M1.66M1.18M-0.14M-1.02M-1.79M-2.09M-2.61M-2.62M
Interest & Investment IncomeInt & Inv Inc
1.79M2.09M2.61M2.62M2.34M2.36M-1.51M-2.55M-3.36M-3.80M-4.68M-4.57M-4.13M-3.74M
Other Non Operating IncomeOther Non Op Inc.
Net income details
EBT
-46.67M-49.14M-26.01M-34.37M-45.58M-35.72M-33.12M-32.53M-21.97M-30.17M-20.47M-13.45M-15.20M-20.05M-23.53M-40.90M-22.19M-90.65M-110.61M-40.22M
Tax ProvisionsTaxes
-6.66M-0.15M-3.60M-0.94M0.16M0.04M0.07M0.09M0.06M0.14M0.11M0.07M-0.47M0.62M0.21M0.08M0.04M0.38M0.41M0.32M
Profit After TaxPAT
-40.01M-48.99M-22.46M-33.43M-45.73M-35.78M-33.19M-32.61M-22.03M-30.31M-20.59M-13.52M-14.73M-20.67M-23.74M-40.98M-22.23M-91.03M-111.03M-40.54M
Income from Continuing OperationsIncome (Continuing)
-40.01M-48.99M-22.41M-33.43M-45.73M-35.76M-33.19M-32.61M-22.03M-30.31M-20.59M-13.52M-14.73M-20.67M-23.74M-40.98M-22.23M-91.03M-111.03M-40.54M
Consolidated Net IncomeConsol Net Inc.
-40.01M-48.99M-22.41M-33.43M-45.73M-35.76M-33.19M-32.61M-22.03M-30.31M-20.59M-13.52M-14.73M-20.67M-23.74M-40.98M-22.23M-91.03M-111.03M-40.54M
Income towards Parent CompanyParent Net Inc
-40.01M-48.99M-22.41M-33.43M-45.73M-35.76M-33.19M-32.61M-22.03M-30.31M-20.59M-13.52M-14.73M-20.67M-23.74M-40.98M-22.23M-91.03M-111.03M-40.54M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-40.01M-48.99M-22.41M-33.43M-45.73M-35.76M-33.19M-32.61M-22.03M-30.31M-20.59M-13.52M-14.73M-20.67M-23.74M-40.98M-22.23M-91.03M-111.03M-40.54M
Additional items
EPS (Basic)
-0.82-1.03-0.42-0.62-0.84-0.67-0.60-0.58-0.39-0.54-0.35-0.23-0.24-0.34-0.35-0.59-0.32-1.30-1.53-0.55
EPS (Diluted)
-0.82-1.03-0.42-0.62-0.84-0.66-0.60-0.58-0.39-0.54-0.35-0.23-0.24-0.34-0.35-0.59-0.32-1.30-1.53-0.55
Shares Outstanding
49.00M47.49M53.01M53.68M54.30M53.72M55.48M55.98M56.71M56.42M58.59M59.30M60.44M60.19M68.55M69.63M70.38M69.90M72.59M73.96M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
49.00M47.49M53.22M53.68M54.30M54.08M55.48M55.98M56.71M56.42M58.59M59.30M60.44M60.19M68.55M69.63M70.38M69.90M72.59M73.96M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
51.93M52.69M53.92M54.71M54.72M55.76M56.26M56.96M57.37M58.53M58.96M60.08M60.85M64.04M69.59M70.37M70.73M72.13M73.85M74.70M
EBITDA
-40.55M-42.77M-22.05M-30.59M-42.72M-33.55M-31.71M-31.42M-21.48M-29.68M-19.51M-12.71M-10.59M-14.20M-16.57M-33.49M-13.71M-82.08M-102.48M-32.78M
Interest ExpensesInt Expense
4.42M4.38M1.66M1.18M-0.14M-1.02M-1.79M-2.09M-2.61M-2.62M
Tax Rate
14.27%0.31%13.84%2.75%-0.34%-0.11%-0.21%-0.26%-0.27%-0.47%-0.55%-0.52%3.12%-3.12%-0.91%-0.20%-0.18%-0.42%-0.37%-0.78%